G protein coupled receptor dimerization: implications in modulating receptor function
暂无分享,去创建一个
Lakshmi A. Devi | L. Devi | B. Jordan | I. Gomes | Bryen A. Jordan | Ivone Gomes | Achla Gupta | N. Trapaidze | Achla Gupta | Carl Rios | Nino Trapaidze | C. Rios
[1] L. Devi,et al. Kappa opioid receptor endocytosis by dynorphin peptides. , 2000, DNA and cell biology.
[2] T. Schwartz,et al. Locating ligand-binding sites in 7TM receptors by protein engineering. , 1994, Current opinion in biotechnology.
[3] Jonathan A Javitch,et al. Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method , 1995, Neuron.
[4] R. Lefkowitz,et al. Beta-adrenergic receptors: evidence for negative cooperativity. , 1975, Biochemical and biophysical research communications.
[5] A. Couvineau,et al. Receptors for VIP, PACAP, Secretin, GRF, Glucagon, GLP‐1, and Other Members of Their New Family of G Protein‐Linked Receptors: Structure‐Function Relationship with Special Reference to the Human VIP‐1 Receptor a , 1996, Annals of the New York Academy of Sciences.
[6] J. Shiloach,et al. Expression, Purification, and Biochemical Characterization of the Amino-terminal Extracellular Domain of the Human Calcium Receptor* , 1999, The Journal of Biological Chemistry.
[7] J. Venter,et al. The size of the mammalian lung beta 2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatography. , 1982, Biochemical and biophysical research communications.
[8] F. Marshall,et al. GABAB receptors - the first 7TM heterodimers. , 1999, Trends in pharmacological sciences.
[9] J. Thorner,et al. Model systems for the study of seven-transmembrane-segment receptors. , 1991, Annual review of biochemistry.
[10] L. Kohn,et al. Specific antibody to the thyrotropin receptor identifies multiple receptor forms in membranes of cells transfected with wild-type receptor complementary deoxyribonucleic acid: characterization of their relevance to receptor synthesis, processing, structure, and function. , 1992, Endocrinology.
[11] L. Potter,et al. Affinities of different cholinergic agonists for the high and low affinity states of hippocampal M1 muscarine receptors. , 1989, The Journal of pharmacology and experimental therapeutics.
[12] H. W. Harris,et al. Disulfide Bonds in the Extracellular Calcium-Polyvalent Cation-sensing Receptor Correlate with Dimer Formation and Its Response to Divalent Cations in Vitro * , 1998, The Journal of Biological Chemistry.
[13] J. Holaday,et al. Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites. , 1989, European journal of pharmacology.
[14] K. Catt,et al. Physicochemical characterization of photoaffinity-labeled angiotensin II receptors. , 1987, Molecular endocrinology.
[15] S. Hirose,et al. Ig-Hepta, a Novel Member of the G Protein-coupled Hepta-helical Receptor (GPCR) Family That Has Immunoglobulin-like Repeats in a Long N-terminal Extracellular Domain and Defines a New Subfamily of GPCRs* , 1999, The Journal of Biological Chemistry.
[16] K. Catt,et al. Solubilization and characterization of adrenal and uterine angiotensin II receptors after photoaffinity labeling. , 1980, The Journal of biological chemistry.
[17] S. Meloche,et al. Hydrodynamic properties of the angiotensin II receptor from bovine adrenal zona glomerulosa. , 1990, The Biochemical journal.
[18] E I Canela,et al. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[19] D. Engelman,et al. Sequence specificity in the dimerization of transmembrane alpha-helices. , 1992, Biochemistry.
[20] A. Golbraikh,et al. A molecular mechanism for the cleavage of a disulfide bond as the primary function of agonist binding to G-protein-coupled receptors based on theoretical calculations supported by experiments. , 1999, European journal of biochemistry.
[21] Michel Bouvier,et al. Functional Significance of Oligomerization of G-protein-coupled Receptors , 2000, Trends in Endocrinology & Metabolism.
[22] B. Hietel,et al. Target size analysis of opioid receptors. No difference between receptor types, but discrimination between two receptor states. , 1986, European journal of biochemistry.
[23] A. Cornea,et al. Gonadotropin-releasing Hormone Receptor Microaggregation , 2001, The Journal of Biological Chemistry.
[24] A. Scheer,et al. Theoretical study of the electrostatically driven step of receptor‐G protein recognition , 1999, Proteins.
[25] Lakshmi A. Devi,et al. Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy , 2000, The Journal of Neuroscience.
[26] J. Garnier,et al. Towards understanding the glycoprotein hormone receptors. , 1991, Biochimie.
[27] R. Snyderman,et al. Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. Role of multiple G proteins and receptor phosphorylation. , 1994, The Journal of biological chemistry.
[28] R. Lefkowitz,et al. Negative cooperativity among beta-adrenergic receptors in frog erythrocyte membranes. , 1976, The Journal of biological chemistry.
[29] A. Valencia,et al. Correlated mutations contain information about protein-protein interaction. , 1997, Journal of molecular biology.
[30] E. Brown,et al. Serpentine receptors for parathyroid hormone, calcitonin and extracellular calcium ions. , 1996, Bailliere's clinical endocrinology and metabolism.
[31] K. Fuxe,et al. Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia 1 Published on the World Wide Web on 12 January 1998. 1 , 1998, Brain Research Reviews.
[32] R. Shigemoto,et al. GABAB-receptor subtypes assemble into functional heteromeric complexes , 1998, Nature.
[33] U. Kumar,et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. , 2000, Science.
[34] C. Reynolds,et al. A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors. , 1997, Journal of medicinal chemistry.
[35] Christian Le Gouill,et al. Selective Modulation of Wild Type Receptor Functions by Mutants of G-Protein-coupled Receptors* , 1999, The Journal of Biological Chemistry.
[36] E. Brown,et al. Dimerization of the Extracellular Calcium-sensing Receptor (CaR) on the Cell Surface of CaR-transfected HEK293 Cells* , 1998, The Journal of Biological Chemistry.
[37] G. Demontis,et al. G protein-linked receptors: pharmacological evidence for the formation of heterodimers. , 1999, The Journal of pharmacology and experimental therapeutics.
[38] J. Wess,et al. Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers* , 1999, The Journal of Biological Chemistry.
[39] J. Holaday,et al. Morphine tolerance increases -noncompetative d binding sites? , 1986 .
[40] E. Escher,et al. Analysis of the adrenal angiotensin II receptor with the photoaffinity labeling method. , 1983, Biochemistry.
[41] I. Siemens,et al. Solubilization and Partial Characterization of Angiotensin II Receptors from Rat Brain , 1991, Journal of neurochemistry.
[42] T. Schwartz,et al. Connectivity and orientation of the seven helical bundle in the tachykinin NK‐1 receptor probed by zinc site engineering. , 1996, The EMBO journal.
[43] A. Spiegel,et al. Mutational analysis of the cysteines in the extracellular domain of the human Ca2+ receptor: effects on cell surface expression, dimerization and signal transduction , 1998, FEBS letters.
[44] F. Ciruela,et al. Characterization of the Dimerization of Metabotropic Glutamate Receptors Using an N‐Terminal Truncation of mGluR1α , 1999, Journal of neurochemistry.
[45] T. Schwartz,et al. Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor , 1995, Nature.
[46] H. Mosberg,et al. Selective modulation of morphine antinociception, but not development of tolerance, by delta receptor agonists. , 1990, European journal of pharmacology.
[47] J. Wess,et al. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. , 1998, Biochemistry.
[48] T. Hökfelt,et al. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites. , 1981, Acta physiologica Scandinavica.
[49] S. Nayfeh,et al. Characterization of the subunit structure of the thyrotropin receptor in the FRTL-5 rat thyroid cell line. , 1987, Endocrinology.
[50] E. Kempner,et al. Structure of the thyrotropin receptor and thyroid adenylate cyclase system as determined by target analysis. , 1984, Biochemistry.
[51] J. Ellory,et al. Molecular size of opiate (enkephalin) receptors in neuroblastoma-glioma hybrid cells as determined by radiation inactivation analysis. , 1983, Journal of Biological Chemistry.
[52] P. Seeman,et al. A Transmembrane Domain-derived Peptide Inhibits D1 Dopamine Receptor Function without Affecting Receptor Oligomerization* , 1998, The Journal of Biological Chemistry.
[53] B. McEwen,et al. Modulation by vasoactive intestinal peptide (VIP) of serotonin receptors in membranes from rat hippocampus , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[54] A. Maggi,et al. beta-Adrenergic regulation of alpha 2-adrenergic receptors in the central nervous system. , 1980, Science.
[55] P. Seeman,et al. Dopamine D2 receptor dimers and receptor-blocking peptides. , 1996, Biochemical and biophysical research communications.
[56] J. Holaday,et al. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence. , 1988, The Journal of pharmacology and experimental therapeutics.
[57] C Higgs,et al. Domain swapping in G-protein coupled receptor dimers. , 1998, Protein engineering.
[58] S. Paglin,et al. Covalent crosslinking of angiotensin II to its binding sites in rat adrenal membranes. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[59] P. Cuatrecasas,et al. Increased biological activity of dimers of oxymorphone and enkephalin: possible role of receptor crosslinking. , 1982, Biochemical and biophysical research communications.
[60] J. Garnier,et al. Monoclonal antibodies against luteinizing hormone receptor. Immunochemical characterization of the receptor. , 1990, Endocrinology.
[61] L. Potter,et al. Evidence of paired M2 muscarinic receptors. , 1991, Molecular pharmacology.
[62] M. Caron,et al. Phosphorylation and Palmitoylation of the Human D2L Dopamine Receptor in Sf9 Cells , 1994, Journal of neurochemistry.
[63] J. Wess. G‐protein‐coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G‐protein recognition , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[64] A. Scheer,et al. Ab initio modeling and molecular dynamics simulation of the alpha 1b-adrenergic receptor activation. , 1998, Methods.
[65] T. Rogers. High affinity angiotensin II receptors in myocardial sarcolemmal membranes. Characterization of receptors and covalent linkage of 125I-angiotensin II to a membrane component of 116,000 daltons. , 1984, The Journal of biological chemistry.
[66] Melanie G. Lee,et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.
[67] John R. Traynor,et al. δ-opioid receptor subtypes and cross-talk with μ-receptors , 1993 .
[68] J. Wess,et al. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[69] L. Devi,et al. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[70] H. Lother,et al. Involvement of the Amino Terminus of the B2 Receptor in Agonist-induced Receptor Dimerization* , 1999, The Journal of Biological Chemistry.
[71] Michel Bouvier,et al. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). , 2000 .
[72] J. Venter,et al. Molecular size of the human platelet alpha 2-adrenergic receptor as determined by radiation inactivation. , 1983, Biochemical and biophysical research communications.
[73] C. Fraser,et al. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. , 1992, The Biochemical journal.
[74] H. Khorana,et al. Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. , 1996, Biochemistry.
[75] S. Coughlin. Expanding horizons for receptors coupled to G proteins: diversity and disease. , 1994, Current opinion in cell biology.
[76] Michel Bouvier,et al. A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.
[77] T. Schwartz,et al. Construction of a High Affinity Zinc Switch in the -Opioid Receptor (*) , 1996, The Journal of Biological Chemistry.
[78] B. O'dowd,et al. Serotonin 5‐HT1B and 5‐HT1D receptors form homodimers when expressed alone and heterodimers when co‐expressed , 1999, FEBS letters.
[79] C. Martínez-A,et al. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[80] E. Brown,et al. Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[81] J. Wess,et al. Molecular basis of receptor/G-protein-coupling selectivity. , 1998, Pharmacology & therapeutics.
[82] J. Venter,et al. Radiation inactivation (target size analysis) of the gonadotropin-releasing hormone receptor: evidence for a high molecular weight complex. , 1985, Endocrinology.
[83] C. Sander,et al. Correlated mutations and residue contacts in proteins , 1994, Proteins.
[84] C. Tanaka,et al. Molecular characterization of muscarinic receptor subtypes in bovine cerebral cortex by radiation inactivation and molecular exclusion h.p.l.c. , 1985, British journal of pharmacology.
[85] J. Bockaert,et al. Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.
[86] H. Khorana,et al. Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site-directed spin labeling study. , 1995, Biochemistry.
[87] Q. Duh,et al. Immunoprecipitation isolates multiple TSH receptor forms from human thyroid tissue. , 1995, Thyroid : official journal of the American Thyroid Association.
[88] O. Gredal,et al. Binding of [3H]SKF 38393 to Dopamine D‐l Receptors in Rat Striatum In Vitro; Estimation of Receptor Molecular Size by Radiation Inactivation , 1987, Journal of neurochemistry.
[89] J. W. Wells,et al. Cooperativity Manifest in the Binding Properties of Purified Cardiac Muscarinic Receptors (*) , 1995, The Journal of Biological Chemistry.
[90] L. Devi,et al. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.
[91] J. Morrison,et al. Expression of Dopamine D3 Receptor Dimers and Tetramers in Brain and in Transfected Cells* , 1997, The Journal of Biological Chemistry.
[92] L. Gama,et al. Dimerization of the Calcium-sensing Receptor Occurs within the Extracellular Domain and Is Eliminated by Cys → Ser Mutations at Cys101 and Cys236 * , 1999, The Journal of Biological Chemistry.
[93] S Avissar,et al. Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[94] U. Gether. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.
[95] T. Asano,et al. Oligomer formation of histamine H2 receptors expressed in Sf9 and COS7 cells 1 , 1997, FEBS letters.
[96] Lakshmi A. Devi,et al. G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.
[97] U. Kumar,et al. Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers* , 2000, The Journal of Biological Chemistry.
[98] P. Seeman,et al. Dopamine D2 receptor dimers in human and rat brain , 1998, FEBS letters.
[99] O. Lichtarge,et al. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F , 1996, Nature.
[100] K. Blumer,et al. G-protein-coupled receptors function as oligomers in vivo , 2000, Current Biology.
[101] D. Clapham,et al. Specificity of receptor-G protein interactions: searching for the structure behind the signal. , 1993, Cellular signalling.
[102] G. Köhr,et al. Role of heteromer formation in GABAB receptor function. , 1999, Science.
[103] Alan Wise,et al. Heterodimerization is required for the formation of a functional GABAB receptor , 1998, Nature.
[104] H. Lother,et al. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration , 2000, Nature.
[105] Robert J. Lefkowitz,et al. β-Adrenergic receptors: Evidence for negative cooperativity , 1975 .
[106] C. Strader,et al. Structure and function of G protein-coupled receptors. , 1994, Annual review of biochemistry.
[107] S. Nakanishi,et al. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.